Although we're past the 42 day window of highest risk, the case count is still increasing. The CDC had predicted additional cases but an increase of 23 new cases is significant. Still, without a more detailed breakout, there's no way for us to know if these additional cases are actually new, or were identified in a retrospective analysis. We also don't know how many, if any, are peripheral joint infections, and/or epidural abscesses.
Today's CDC update does not include any changes to the Current Situation, or to the Clinician or Patient Guidance. There are no FDA updates on information about NECC, but the inspection report for its' sister company Ameridose has been posted on a separate FDA page (see thread here).
- Status: Ongoing Investigation
- Infection: Fungal
- Facility Type: Outpatient Setting
- Case Count: 461*
- States: 19*
- Deaths: 32*